Fight CRC Clinical Trial Finder
| NCT ID | Title | 阶段 | Date Added | 地点 | Prior IO Allowed | CRC-directed | Status | 药物 | 标签 |
|---|---|---|---|---|---|---|---|---|---|
| NCT ID NCT06152523 |
TitleMonalizumab and MEDI5752 in Patients With MSI and/or dMMR Metastatic Cancer | 阶段
第二阶段
|
Date Added 2023-11-30 |
地点
法国
|
Prior IO Allowed 没有 |
CRC-directed 是 |
Status
尚未招聘
|
药物
Monalizumab/MEDI5257 |
标签
MSI-H/ MMRd
|
| NCT ID NCT02285816 |
TitleMG1 Maraba/MAGE-A3, With and Without Adenovirus Vaccine With Transgenic MAGE-A3 Insertion in Incurable MAGE-A3-Expressing Solid Tumours | 阶段
Phase 1, Phase 2
|
Date Added 2014-11-07 |
地点
加拿大
|
Prior IO Allowed 是 |
CRC-directed 没有 |
Status
活跃，非招募
|
药物
AdMA3, MG1MA3 |
标签
MSS/ MMRp
|
| NCT ID NCT03388190 |
TitleMETIMMOX: Colorectal Cancer METastasis – Shaping Anti-tumor IMMunity by OXaliplatin | 阶段
第二阶段
|
Date Added 2018-01-02 |
地点
挪威
|
Prior IO Allowed 没有 |
CRC-directed 是 |
Status
活跃，非招募
|
药物
FLOX, Nivolumab, Opdivo |
标签
MSS/ MMRp
|
| NCT ID NCT03925662 |
Title甲苯咪唑作为结肠癌的辅助治疗药物 | 阶段
第三阶段
|
Date Added 2019-04-24 |
地点
埃及
|
Prior IO Allowed 没有 |
CRC-directed 是 |
Status
招聘
|
药物
Folfox with avastin, Mebendazole |
标签
MSI-H/ MMRd, MSS/ MMRp
|
| NCT ID NCT06514651 |
TitleMAQ-001 in Patients With Advanced Solid Tumors | 阶段
第 1 阶段
|
Date Added 2024-07-23 |
地点
法国
|
Prior IO Allowed 是 |
CRC-directed 没有 |
Status
招聘
|
药物 |
标签
MSI-H/ MMRd
|
| NCT ID NCT05286814 |
TitleM9241 与肝动脉输注泵 (HAIP) 和全身疗法联合用于转移性结直肠癌或肝内胆管癌患者的治疗 | 阶段
第二阶段
|
Date Added 2022-03-18 |
地点
Maryland, United States
|
Prior IO Allowed 没有 |
CRC-directed 是 |
Status
招聘
|
药物 |
标签
MSS/ MMRp
|
| NCT ID NCT04874259 |
TitleLT治疗无法切除的结直肠肝转移瘤 | 阶段
不适用
|
Date Added 2021-05-05 |
地点
大韩民国
|
Prior IO Allowed 没有 |
CRC-directed 是 |
Status
招聘
|
药物 |
标签
MSI-H/ MMRd, MSS/ MMRp
|
| NCT ID NCT06310564 |
TitleLow and Intermediate Risk oliGometastatic coloREctal cancEr patieNts Treated With Stereotactic ABlative Radiotherapy | 阶段
不适用
|
Date Added 2024-03-15 |
地点
意大利
|
Prior IO Allowed 是 |
CRC-directed 是 |
Status
招聘
|
药物 |
标签
MSI-H/ MMRd, MSS/ MMRp
|
| NCT ID NCT04062721 |
TitleLocal Immunomodulation After Radiofrequency of Unresectable Colorectal Liver Metastases | 阶段
第 1 阶段
|
Date Added 2019-08-20 |
地点
法国
|
Prior IO Allowed 是 |
CRC-directed 是 |
Status
尚未招聘
|
药物
Chemotherapy, In situ immunotherapy |
标签
MSS/ MMRp
|
| NCT ID NCT03488953 |
Title为孤立、不可切除的结直肠肝转移患者进行活体肝移植和两期肝切除术 | 阶段
不适用
|
Date Added 2018-04-05 |
地点
德国
|
Prior IO Allowed 没有 |
CRC-directed 是 |
Status
招聘
|
药物 |
标签
MSI-H/ MMRd, MSS/ MMRp
|
